Diagnosis and clinical severity markers of bullous pemphigoid.
The use of a broad spectrum of novel detection systems for autoantibodies to the basement membrane proteins BP180 and BP230 has greatly facilitated the diagnosis of bullous pemphigoid, which most likely explains its increasing incidence in central Europe. Because the pathogenic relevance of antibodies to human BP180 has been convincingly shown both in vitro and in vivo, repeated testing for these antibodies appears to be helpful in guiding treatment decisions during the course of the disease.
Department of Dermatology, University of Lübeck Ratzeburger Allee 160, D-23538 Lübeck Germany.
Enno
E
Schmidt
Detlef
D
Zillikens